During the past decade, Kreiskrankenhaus Rottweil conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kreiskrankenhaus Rottweil" are "Bradycardia; Sick Sinus Syndrome, AV Block" (1 trials) and "Rectal Neoplasms" (1 trials). Many other conditions were trialed in "Kreiskrankenhaus Rottweil" in a lesser frequency.

Most popular intervention types in "Kreiskrankenhaus Rottweil" are "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials), "Required pacemaker setting" (1 trials) and "Vitatron C50 D Model C50A2 of Vitatron C60 DR model C60A2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kreiskrankenhaus Rottweil" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kreiskrankenhaus Rottweil". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kreiskrankenhaus Rottweil, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kreiskrankenhaus Rottweil, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".